1. Home
  2. CMTL vs SGMO Comparison

CMTL vs SGMO Comparison

Compare CMTL & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

HOLD

Current Price

$3.74

Market Cap

162.1M

Sector

Technology

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.25

Market Cap

141.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMTL
SGMO
Founded
1967
1995
Country
United States
United States
Employees
1385
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.1M
141.2M
IPO Year
2024
2000

Fundamental Metrics

Financial Performance
Metric
CMTL
SGMO
Price
$3.74
$0.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$7.00
AVG Volume (30 Days)
336.9K
6.5M
Earning Date
03-16-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.20
EPS
N/A
N/A
Revenue
$499,528,000.00
$36,567,000.00
Revenue This Year
N/A
$24.46
Revenue Next Year
$4.56
$193.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
88.60
52 Week Low
$1.19
$0.21
52 Week High
$6.21
$0.84

Technical Indicators

Market Signals
Indicator
CMTL
SGMO
Relative Strength Index (RSI) 43.66 33.90
Support Level $2.82 N/A
Resistance Level $6.15 $0.55
Average True Range (ATR) 0.32 0.04
MACD 0.06 -0.01
Stochastic Oscillator 85.96 24.19

Price Performance

Historical Comparison
CMTL
SGMO

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: